145 related articles for article (PubMed ID: 1920118)
1. Inhibition of thromboxane synthetase potentiates the antihypertensive action of an angiotensin-converting enzyme inhibitor by a prostaglandin-dependent but kinin-independent mechanism.
Levens NR; Cóte D; Ksander G
J Pharmacol Exp Ther; 1991 Oct; 259(1):219-27. PubMed ID: 1920118
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane synthase inhibition enhances action of converting enzyme inhibitors.
Levens NR; Ksander GM; Zimmerman MB; Mullane KM
Hypertension; 1989 Jan; 13(1):51-62. PubMed ID: 2910814
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
Bitterman H; Phillips GR; Dragon G; Lefer AM
J Pharmacol Exp Ther; 1987 Jul; 242(1):8-14. PubMed ID: 3039116
[TBL] [Abstract][Full Text] [Related]
4. Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats.
Daull P; Blouin A; Sirois P; Nantel F; Jeng AY; Battistini B
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S398-401. PubMed ID: 15838331
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive action of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride in hypertensive rat models.
Tanaka M; Yamamoto S; Nakao K; Inukai T; Ogawa N; Katsumura H; Ohara N; Shukunobe K; Ono H
Arzneimittelforschung; 1991 Jun; 41(6):608-12. PubMed ID: 1930348
[TBL] [Abstract][Full Text] [Related]
6. Preliminary observations of the acute effects of selective serum thromboxane inhibition and angiotensin converting enzyme inhibition on blood pressure and renal hemodynamics in hypertensive humans.
Weir MR; Klassen DK; Hoover N; Douglas FL
J Clin Pharmacol; 1989 Dec; 29(12):1108-16. PubMed ID: 2693500
[TBL] [Abstract][Full Text] [Related]
7. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
Chan PS; Ronsberg MA; Cervoni P
Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
[TBL] [Abstract][Full Text] [Related]
8. Rapid reversal of angiotensin I-induced contractions in rat carotid arteries after acute and chronic treatment with the angiotensin-converting enzyme inhibitor, 3-[(5-amino-1-carboxy-1S-pentyl)amino]2,3,4,5-tetrahydro-2-oxo- 3S-1H-1-benzazepena-1-acetic acid (CGS 16617).
Weiss GB; Sturm B; Levens NR
J Pharmacol Exp Ther; 1993 Dec; 267(3):1407-13. PubMed ID: 8263802
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure effects of thromboxane A2 blockade in spontaneously hypertensive rats.
Boussairi EH; Sacquet J; Benzoni D; Sassard J
Clin Exp Pharmacol Physiol; 1993 Nov; 20(11):679-87. PubMed ID: 8306513
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
[TBL] [Abstract][Full Text] [Related]
11. Renal actions of the new angiotensin converting enzyme inhibitor CGS 16617.
Levens NR
Arch Int Pharmacodyn Ther; 1988; 292():266-80. PubMed ID: 2840040
[TBL] [Abstract][Full Text] [Related]
12. Effects of benazepril, an angiotensin-converting enzyme inhibitor, combined with CGS 35066, a selective endothelin-converting enzyme inhibitor, on arterial blood pressure in normotensive and spontaneously hypertensive rats.
Battistini B; Ayach B; Molez S; Blouin A; Jeng AY
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():363S-366S. PubMed ID: 12193123
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570).
Brown NL; Badel MY; Benzoni F; Zanirato J; Vincent JC; Fichelle J; Worcel M
Eur J Pharmacol; 1988 Mar; 148(1):79-91. PubMed ID: 3383998
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
Säynävälammi P; Pörsti I
Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
[TBL] [Abstract][Full Text] [Related]
16. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs.
Grauer GF; Greco DS; Behrend EN; Fettman MJ; Mani I; Getzy DM; Reinhart GA
Am J Vet Res; 1996 Jun; 57(6):948-56. PubMed ID: 8725828
[TBL] [Abstract][Full Text] [Related]
17. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
18. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
[TBL] [Abstract][Full Text] [Related]
19. Effects of des-aspartate-angiotensin I on the actions of angiotensin III in the renal and mesenteric vasculature of normo- and hypertensive rats.
Mustafa MR; Dharmani M; Kunheen NK; Sim MK
Regul Pept; 2004 Aug; 120(1-3):15-22. PubMed ID: 15177916
[TBL] [Abstract][Full Text] [Related]
20. Secretory dysfunction of vascular endothelium limits the effect of angiotensin converting enzyme inhibitor quinapril on aggregation of erythrocytes in experimental hypertension.
Korbut RA; Madej J; Adamek-Guzik T; Korbut R
J Physiol Pharmacol; 2003 Sep; 54(3):397-408. PubMed ID: 14566078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
